
Meta-Analysis Compares Hidradenitis Suppurativa Treatments
TOPLINE: In a network meta-analysis of 25 randomized trials, sonelokimab was ranked highest for treating patients with moderate-to-severe hidradenitis suppurativa (HS). Adalimumab, lutikizumab, and bimekizumab were also ranked high. METHODOLOGY: …